-
EP1514930
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1514930
| EP1514930 - NOVEL SCREENING METHOD [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 14.12.2018 Database last updated on 12.06.2024 | |
| Former | Grant of patent is intended Status updated on 11.03.2018 | ||
| Former | Examination is in progress Status updated on 12.12.2017 | ||
| Former | Grant of patent is intended Status updated on 26.07.2017 | ||
| Former | Examination is in progress Status updated on 04.11.2016 | Most recent event Tooltip | 14.12.2018 | Application deemed to be withdrawn | published on 16.01.2019 [2019/03] | Applicant(s) | For all designated states Takeda Pharmaceutical Company Limited 1-1, Doshomachi 4-chome Chuo-ku Osaka 541-0045 / JP | [N/P] |
| Former [2005/11] | For all designated states Takeda Pharmaceutical Company Limited 1-1, Doshomachi 4-chome Chuo-ku Osaka 541-0045 / JP | Inventor(s) | 01 /
HINUMA, Shuji 7-9-1402, Kasuga 1-chome Tsukuba-shi, Ibaraki 305-0821 / JP | 02 /
FUJII, Ryo 33-16, Kasuga 2-chome Tsukuba-shi, Ibaraki 305-0821 / JP | 03 /
HARADA, Masataka 14-5-201, Higashi 2-chome Tsukuba-shi, Ibaraki 305-0046 / JP | 04 /
HOSOYA, Masaki 711-83, Itaya 1-chome Tsuchiura-shi, Ibaraki 300-0007 / JP | [2005/11] | Representative(s) | König, Gregor Sebastian, et al König-Szynka-Tilmann-von Renesse Patentanwälte Partnerschaft mbB Postfach 11 09 46 40509 Düsseldorf / DE | [N/P] |
| Former [2009/30] | König, Gregor Sebastian, et al König Szynka Tilmann von Renesse Patentanwälte Partnerschaft Lohengrinstrasse 11 40549 Düsseldorf / DE | ||
| Former [2005/11] | Lewin, John Harvey Takeda Patent Office, 11-12 Charles II Street London SW1Y 4QU / GB | Application number, filing date | 03733385.3 | 12.06.2003 | [2005/11] | WO2003JP07500 | Priority number, date | JP20020173798 | 14.06.2002 Original published format: JP 2002173798 | JP20020205470 | 15.07.2002 Original published format: JP 2002205470 | [2005/11] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO03106683 | Date: | 24.12.2003 | Language: | EN | [2003/52] | Type: | A1 Application with search report | No.: | EP1514930 | Date: | 16.03.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.12.2003 takes the place of the publication of the European patent application. | [2005/11] | Search report(s) | International search report - published on: | JP | 24.12.2003 | (Supplementary) European search report - dispatched on: | EP | 26.10.2006 | Classification | IPC: | C12N15/12, A61K38/17, A61K45/00, A61P9/00, A61P25/00, A61P25/14, A61P25/16, A61P25/28, A61P43/00, G01N33/50, G01N33/15, G01N33/566 | [2005/11] | CPC: |
G01N33/74 (EP,US);
A61P25/00 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/28 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
C07K14/4747 (EP,US);
C07K14/705 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/11] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | NEUES SCREENING-VERFAHREN | [2005/11] | English: | NOVEL SCREENING METHOD | [2005/11] | French: | PROCEDE DE CRIBLAGE | [2005/11] | Entry into regional phase | 21.12.2004 | Translation filed | 21.12.2004 | National basic fee paid | 21.12.2004 | Search fee paid | 21.12.2004 | Designation fee(s) paid | 21.12.2004 | Examination fee paid | Examination procedure | 10.07.2003 | Request for preliminary examination filed International Preliminary Examining Authority: JP | 21.12.2004 | Examination requested [2005/11] | 03.12.2008 | Despatch of a communication from the examining division (Time limit: M04) | 03.04.2009 | Reply to a communication from the examining division | 24.03.2010 | Despatch of a communication from the examining division (Time limit: M06) | 27.09.2010 | Reply to a communication from the examining division | 11.04.2013 | Despatch of a communication from the examining division (Time limit: M04) | 18.07.2013 | Reply to a communication from the examining division | 26.06.2015 | Despatch of a communication from the examining division (Time limit: M06) | 06.01.2016 | Reply to a communication from the examining division | 25.10.2016 | Despatch of a communication from the examining division (Time limit: M06) | 28.04.2017 | Reply to a communication from the examining division | 27.07.2017 | Communication of intention to grant the patent | 06.12.2017 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 12.03.2018 | Communication of intention to grant the patent | 24.07.2018 | Application deemed to be withdrawn, date of legal effect [2019/03] | 31.08.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2019/03] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 03.12.2008 | Fees paid | Renewal fee | 21.12.2004 | Renewal fee patent year 03 | 27.03.2006 | Renewal fee patent year 04 | 14.06.2007 | Renewal fee patent year 05 | 28.03.2008 | Renewal fee patent year 06 | 16.06.2009 | Renewal fee patent year 07 | 11.06.2010 | Renewal fee patent year 08 | 13.06.2011 | Renewal fee patent year 09 | 24.05.2012 | Renewal fee patent year 10 | 10.06.2013 | Renewal fee patent year 11 | 12.06.2014 | Renewal fee patent year 12 | 10.06.2015 | Renewal fee patent year 13 | 10.06.2016 | Renewal fee patent year 14 | 16.06.2017 | Renewal fee patent year 15 | 11.06.2018 | Renewal fee patent year 16 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [ ] - No further relevant documents disclosed | International search | [A]WO0031261 (CADUS PHARMACEUTICAL CORP [US]); | [XP] - YING G.G. ET AL., "Humanin, a newly identified neuroprotective factor uses the G-protein coupled receptor FPRL1 as a functional receptor", J. INTERFERON AND CYTOKINE RESEARCH, (2002), vol. 22, no. SUPPL. 1, page S-180, XP002970485 | [A] - MURPHY P.M. ET AL., "A structural homologue of the N-formyl peptide receptor, characterization and chromosome mapping of a peptide chemoattractant receptor family", J. BIOL. CHEM., (19920415), vol. 267, no. 11, pages 7637 - 7643, XP002137531 | [A] - DURSTIN M. ET AL., "Differential expression of members of the N-formylpeptide receptor gene cluster in human phagocytes", BIOCHEM. BIOPHYS. RES. COMMUN., (19940530), vol. 201, no. 1, pages 174 - 179, XP002973362 DOI: http://dx.doi.org/10.1006/bbrc.1994.1685 | [A] - KLEIN C. ET AL., "Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast", NAT. BIOTECHNOL., (199812), vol. 16, no. 13, pages 1334 - 1347, XP002137534 DOI: http://dx.doi.org/10.1038/4310 | [A] - LE Y. ET AL., "The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1", J. IMMUNOL., (20010201), vol. 166, no. 3, pages 1448 - 1451, XP002973363 | [A] - YANG D. ET AL., "LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes and T cells", J. EXP. MED., (20001002), vol. 192, no. 7, pages 1069 - 1074, XP002973364 DOI: http://dx.doi.org/10.1084/jem.192.7.1069 | [A] - LE Y. ET AL., "Receptors for chemotactic formyl peptides as pharmacological targets", INT. IMMUNOPHARMACOL., (200201), vol. 2, no. 1, pages 1 - 13, XP002249587 DOI: http://dx.doi.org/10.1016/S1567-5769(01)00150-3 | [A] - CHRISTOPHE T. ET AL., "The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2", J. BIOL. CHEM., (20010615), vol. 276, no. 24, pages 21585 - 21593, XP002973365 DOI: http://dx.doi.org/10.1074/jbc.M007769200 | [A] - VAUGHN M.W. ET AL., "Identification, cloning and functional characterization of a murine lipoxin A4 receptor homologue gene", J. IMMUNOL., (20020915), vol. 169, no. 6, pages 3363 - 3369, XP002973366 | [A] - HASHIMOTO Y. ET AL., "A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta", PROC. NATL. ACAD. SCI. USA, (20010522), vol. 98, no. 11, pages 6336 - 6341, XP002190962 DOI: http://dx.doi.org/10.1073/pnas.101133498 |